Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
June 06 2025 - 4:23PM
Edgar (US Regulatory)
Exhibit 1
Joint Filing Agreement
The undersigned hereby agree as follows:
(i) Each of them is individually eligible to use the Schedule 13D to which this Exhibit is attached,
and such Schedule 13D is filed on behalf of each of them; and
(ii) Each of them is responsible for the timely filing of such Schedule 13D and any amendments
thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless
such person knows or has reason to believe that such information is inaccurate.
Date: June 6, 2025
|
|
Blue Horizon Enterprise Ltd.
|
|
|
|
|
|
|
|
|
By:
|
/s/ Eleni Constantinou Kyriacou
|
|
|
|
Name:
|
Eleni Constantinou Kyriacou
|
|
|
|
Title:
|
Director
|
|
|
|
|
|
|
|
|
Ezbon International Limited
|
|
|
|
|
|
|
By:
|
/s/ Eleni Constantinou Kyriacou
|
|
|
|
Name:
|
Eleni Constantinou Kyriacou
|
|
|
|
Title:
|
Director
|
|
|
|
Montrago Trustees Limited
|
|
|
|
|
|
|
|
|
By:
|
/s/ Androulla Papadopoulou
|
|
|
|
Name:
|
Androulla Papadopoulou
|
|
|
|
Title:
|
Director
|
|
|
|
|
|
|
|
|
Skorpios Trust
|
|
|
|
|
|
|
By:
|
/s/ Androulla Papadopoulou
|
|
|
|
Name:
|
Androulla Papadopoulou
|
|
|
|
Title:
|
Director
|
|
Stoke Therapeutics (NASDAQ:STOK)
Historical Stock Chart
From Jun 2025 to Jul 2025
Stoke Therapeutics (NASDAQ:STOK)
Historical Stock Chart
From Jul 2024 to Jul 2025
